openPR Logo
Press release

Non-steroidal anti-inflammatory drugs Market: Analysis Report, Share, Trends and Overview 2021-2027

10-05-2021 08:10 AM CET | Health & Medicine

Press release from: Orion Market Research

The Global Non-steroidal anti-inflammatory drugs market is estimated to grow at a significant CAGR during the forecast period. FDA-approved antipyretic, anti-inflammatory, and analgesic drugs are known as nonsteroidal anti-inflammatory drugs (NSAIDs). NSAIDs are used to treat arthritic diseases, muscular pain, gout, dysmenorrhea pyrexia, migraines, and as opioid-sparing drugs in some acute trauma cases because of these effects.
Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used to treat pain and inflammation. The rising prevalence of ankylosing spondylitis, osteoarthritis, rheumatoid arthritis, migraine, and other immune disorders is driving up demand for these drugs. These have become the most widely prescribed drugs in the globe, as the number of prescriptions has increased. Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, naproxen and diclofenac have been shown to be highly effective in suppressing the pain caused by osteoarthritis, and they can cause stomach pain, cardiovascular disorder, hemorrhage problems, and liver and kidney damage. NSAID gels have also been shown to relieve pain while having fewer adverse effects. Doctors are increasingly prescribing biologics, a new type of anti-inflammatory drug. Due to a rise in obesity, sedentary lifestyles and bad eating habits, the risk of arthritis has increased.

A full report of Non-steroidal anti-inflammatory drugs Market is available at: https://www.omrglobal.com/industry-reports/non-steroidal-anti-inflammatory-drugs-market

In the United States, over 84 million NSAID prescriptions are written each year, according to Endo International plc. This is expected to boost the market's growth. Furthermore, the Centers for Disease Control and Prevention's positive recommendations on the use of non-opioid drugs for the treatment of pain would aid the market's growth.

In May 2019, The FDA had approved an Abbreviated New Drug Application (ANDA) for Voltaren Gel, according to Perrigo Company plc. This is likely to have a beneficial influence on the market for NSAIDs.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/non-steroidal-anti-inflammatory-drugs-market

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment covered
o By Type
o By Application
o By distribution Channel
• Region Covered
o North America
o Europe
o Asia-Pacific
o Rest of the world
• Competitive Landscape- Pfizer Inc., Amgen Inc., GlaxoSmithKline PLC., Johnson & Johnson., Novartis AG., and F. Hoffmann-La Roche AG., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Market Segmentation

By Type

• Oral
• Parenteral

By Application

• Arthritis
• Migraine
• Ophthalmic Diseases
• Other Applications

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Others Distribution Channels

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/non-steroidal-anti-inflammatory-drugs-market

Non-steroidal anti-inflammatory drugs Market– Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• Pfizer Inc.
• Amgen Inc.
• GlaxoSmithKline PLC.
• Johnson & Johnson.
• Novartis AG.
• F. Hoffmann-La Roche AG.

Reasons to Buying From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Non-steroidal anti-inflammatory drugs Market: Analysis Report, Share, Trends and Overview 2021-2027 here

News-ID: 2416835 • Views: 195

More Releases from Orion Market Research

Vehicle Reseller Market 2021 Size, Growth Analysis Report, Forecast to 2027
The global vehicle reseller market is anticipated to grow at a considerable CAGR of 8.0% during the forecast period (2021-2027). The rise in competition among the market and the threat of new entries are the factors will bolster the growth of the vehicle reselling dealership business. The reliable & add on service and quality has changed the perspective of consumers toward the used vehicle business. In addition, franchised dealers along
Metamaterial Technology Market Size | COVID-19 Impact Analysis | Forecast to 202 …
The global metamaterial technology market is anticipated to grow at a significant CAGR of around 3022.5% during the forecast period. The rising investment in defence sector by the major economies is the prominent factor accelerating the market growth. For instance, according to the Peterson Foundation report 2021, in the US, in 2020, defense spending accounts $778 billion or more than 10% of all federal spending and nearly half of the
Global Triamcinolone Ointment Chlorofluorocarbons Market Trends 2021 | Segmentat …
The global triamcinolone ointment chlorofluorocarbons market is expected to grow at a significant CAGR during the forecast period (2021-2027). Skin disease affects millions of people across the globe and is one of the primary causes of the rising global disease burden. Triamcinolone is a drug that is used to treat inflammation in a variety of diseases such as allergic responses, eczema, and psoriasis. A variety of skin diseases are caused
Global Sleep Disorder Treatment Drugs Market Size, Share, Analysis, Industry Rep …
The global sleep disorder treatment drugs market is expected to grow at a significant CAGR during the forecast period (2021-2027). Sleep disorders are becoming more common across the globe, rising stress levels, a growing geriatric population, and increased awareness about various treatment choices for this disease are all likely to drive the market growth. According to the Narcolepsy Network, nearly one out of every 2,000 persons in the US

All 5 Releases


More Releases for NSAID

Non-Steroidal Anti-Inflammatory Drugs (Nsaid) Market 2020-2027 Business Trend an …
Global Non-Steroidal Anti-Inflammatory Drugs (Nsaid) Market Research Report 2020 offers information on market growth, in-depth research and competitive insights as well as segmentation. Additionally, this report examines the import/export value of Non-Steroidal Anti-Inflammatory Drugs (Nsaid) Market, production, development plans, investment plan, cost structure, and driver analysis. This report also helps in understanding the competition amongst the prime market players and determines the SWOT analysis of Non-Steroidal Anti-Inflammatory Drugs (Nsaid) Market. It
NSAID API Market Analysis 2012 to 2017 - Industry Trends and Forecast 2017-2025
"The Latest Research Report NSAID API Market - Global Industry Trend Analysis 2012 to 2017 and Forecast 2017 - 2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Active pharmaceutical ingredients (APIs) are bulk drug products that are used as raw materials for formulations. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that groups together drugs that provide analgesic (pain-killing) and antipyretic
NSAID API Market Growth to Remain Stable during 2017 - 2025
Active pharmaceutical ingredients (APIs) are bulk drug products that are used as raw materials for formulations. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that groups together drugs that provide analgesic (pain-killing) and antipyretic (fever-reducing) effects, and, in higher doses, anti-inflammatory effects. The term nonsteroidal distinguishes these drugs from steroids, which, among a broad range of other effects, have a similar eicosanoid-depressing, anti-inflammatory action. APIs of good quality is essential
NSAID API Market Expected to Rise Steadily throughout 2017-2025
Active pharmaceutical ingredients (APIs) are bulk drug products that are used as raw materials for formulations. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that groups together drugs that provide analgesic (pain-killing) and antipyretic (fever-reducing) effects, and, in higher doses, anti-inflammatory effects. A sample of this report is available upon request @ https://www.persistencemarketresearch.com/samples/17038 The term nonsteroidal distinguishes these drugs from steroids, which, among a broad range of other effects, have a
Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market 2017 : Bayer, Novacap …
Non-steroidal Anti-inflammatory Drugs(NSAID) Market 2017 A market study based on the " Non-steroidal Anti-inflammatory Drugs(NSAID) Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market 2017’. The research report analyses the historical as well as present performance of the worldwide Non-steroidal Anti-inflammatory Drugs(NSAID) industry, and makes predictions on the future status of Non-steroidal Anti-inflammatory Drugs(NSAID) market on the basis of this
NSAID API Market Trends and Opportunities by 2017 – 2025
Active pharmaceutical ingredients (APIs) are bulk drug products that are used as raw materials for formulations. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that groups together drugs that provide analgesic (pain-killing) and antipyretic (fever-reducing) effects, and, in higher doses, anti-inflammatory effects. The term nonsteroidal distinguishes these drugs from steroids, which, among a broad range of other effects, have a similar eicosanoid-depressing, anti-inflammatory action. APIs of good quality is essential